BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

Ecolab Digital Center in India Opens New Office Space in Bangalore, Emphasizing Sustainability and Innovation

This milestone event was marked by a modest ceremony attended by David L. Bingenheimer, alongside the Ecolab leadership team and distinguished guests. A C...

April 10, 2024 | News

Waters Corporation Launches Next-Gen Alliance iS Bio HPLC System for Enhanced QC in Biopharma

New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and elim...

April 10, 2024 | News

Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline

In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...

April 03, 2024 | News

C2 Pharma Announces Launch of New API, Oxybuprocaine Hydrochloride, Enhancing Pain Management Solutions

Oxybuprocaine (also known as Benoxinate), is a local topical anesthetic used especially in ophthalmology and otolaryngology for short term medical procedur...

March 11, 2024 | News

Chime Biologics Secures ISO/IEC 27001:2022 Certification, Bolstering Information Security

Chime Biologics, a leading global CDMO that enables its partners' success in biologics,announced that it has obtained ISO/IEC 27001:2022 certification on i...

March 08, 2024 | News

Australian Telix Boosts US Presence with IsoTherapeutics Acquisition

Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract m...

February 27, 2024 | News

Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process

This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...

February 23, 2024 | News

Mastering the Regulatory Puzzle: Strategies for Biopharmaceutical Success in APAC's Diverse Landscape

The Asia-Pacific (APAC) region, with its burgeoning economies and rapidly expanding healthcare infrastructure, is a fertile ground for biopharmaceutical in...

February 20, 2024 | Regulatory

FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...

February 15, 2024 | News

Luye Pharma Licenses Rivastigmine Patch to Myung In Pharm for South Korea Commercialization

The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...

February 06, 2024 | News

Glenmark, Jiangsu Alphamab, and 3D Medicines Ink Global License Deal for Envafolimab (KN035)

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...

January 26, 2024 | News

Molecule AI Spearheads Pharmaceutical Transformation with AI-Driven Drug Discovery Innovations

Molecule AI, on a mission to accelerate drug discovery through the innovative use of artificial intelligence, is making significant...

January 20, 2024 | News

Mundipharma Greenlights European Approval for REZZAYO® in Treating Adult Invasive Candidiasis

The approval is based on the positive results of the pivotal Phase III ReSTORE clinical trial and is supported by STRIVE's Phase II clinical trials and a...

January 01, 2024 | News

Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...

January 01, 2024 | News

Stay Connected